Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 May 29;306(6890):1475. doi: 10.1136/bmj.306.6890.1475

Triazolam. As safe as other benzodiazepines.

T G Dinan, B E Leonard
PMCID: PMC1677854  PMID: 8518653

Full text

PDF

Page 1475

1475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bixler E. O., Kales A., Manfredi R. L., Vgontzas A. N., Tyson K. L., Kales J. D. Next-day memory impairment with triazolam use. Lancet. 1991 Apr 6;337(8745):827–831. doi: 10.1016/0140-6736(91)92524-6. [DOI] [PubMed] [Google Scholar]
  2. Crook T. Nomifensine in the depressed elderly patient: discussion. J Clin Psychiatry. 1984 Apr;45(4 Pt 2):102–105. [PubMed] [Google Scholar]
  3. Greenblatt D. J., Harmatz J. S., Zinny M. A., Shader R. I. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med. 1987 Sep 17;317(12):722–728. doi: 10.1056/NEJM198709173171202. [DOI] [PubMed] [Google Scholar]
  4. O'Donovan M. C., McGuffin P. Short acting benzodiazepines. BMJ. 1993 Apr 10;306(6883):945–946. doi: 10.1136/bmj.306.6883.945. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES